This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | Next revision Both sides next revision | ||
home:publications [09.12.2019 10:44] Teemu Kuulasmaa [2019] |
home:publications [09.12.2019 13:01] Juha Kekäläinen |
||
---|---|---|---|
Line 7: | Line 7: | ||
Karttunen, J.; Heiskanen, M.; Lipponen, A.; Poulsen, D.; Pitkänen, A. **Extracellular Vesicles as Diagnostics and Therapeutics for Structural Epilepsies**, | Karttunen, J.; Heiskanen, M.; Lipponen, A.; Poulsen, D.; Pitkänen, A. **Extracellular Vesicles as Diagnostics and Therapeutics for Structural Epilepsies**, | ||
+ | |||
+ | Paananen, J; Fortino, V. **An omics perspective on drug target discovery platforms.**, | ||
Failli M, Paananen J, Fortino V. **Prioritizing target-disease associations with novel safety and efficacy scoring methods**, //Sci Rep// 2019, https:// | Failli M, Paananen J, Fortino V. **Prioritizing target-disease associations with novel safety and efficacy scoring methods**, //Sci Rep// 2019, https:// |